Eduardo Tschen

3.3k total citations
48 papers, 2.1k citations indexed

About

Eduardo Tschen is a scholar working on Dermatology, Epidemiology and Cell Biology. According to data from OpenAlex, Eduardo Tschen has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Dermatology, 24 papers in Epidemiology and 8 papers in Cell Biology. Recurrent topics in Eduardo Tschen's work include Nail Diseases and Treatments (18 papers), Dermatology and Skin Diseases (13 papers) and Acne and Rosacea Treatments and Effects (11 papers). Eduardo Tschen is often cited by papers focused on Nail Diseases and Treatments (18 papers), Dermatology and Skin Diseases (13 papers) and Acne and Rosacea Treatments and Effects (11 papers). Eduardo Tschen collaborates with scholars based in United States, Switzerland and Belgium. Eduardo Tschen's co-authors include John E. Wolf, Elise A. Olsen, David M. Pariser, Joseph R. Taylor, Frank Dunlap, Ronald J. Trancik, James M. Swinehart, Carol L. Kulp‐Shorten, Michael K. McCray and Scott D. Glazer and has published in prestigious journals such as The Journal of Immunology, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Eduardo Tschen

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo Tschen United States	22	1.4k	901	448	267	264	48	2.1k
Dong‐Youn Lee South Korea	22	904 0.6×	480 0.5×	406 0.9×	224 0.8×	126 0.5×	142	1.8k
Dimitris Rigopoulos Greece	24	986 0.7×	421 0.5×	345 0.8×	91 0.3×	308 1.2×	70	1.7k
Nabil Kerrouche France	26	1.7k 1.2×	873 1.0×	405 0.9×	169 0.6×	43 0.2×	58	2.2k
Norma Cameli Italy	22	967 0.7×	396 0.4×	287 0.6×	113 0.4×	125 0.5×	77	1.4k
Heidemarie Rossiter Austria	20	323 0.2×	368 0.4×	310 0.7×	143 0.5×	84 0.3×	32	1.4k
Francesca Farnetani Italy	25	1.1k 0.7×	606 0.7×	257 0.6×	1.1k 4.3×	44 0.2×	138	2.0k
Alvin S. Zelickson United States	25	581 0.4×	247 0.3×	648 1.4×	207 0.8×	33 0.1×	52	1.8k
Mark Ling United States	21	1.1k 0.8×	684 0.8×	129 0.3×	245 0.9×	9 0.0×	34	1.7k
Ross StC. Barnetson Australia	22	642 0.4×	383 0.4×	188 0.4×	128 0.5×	10 0.0×	70	1.4k
Eun Joo Park South Korea	19	505 0.4×	183 0.2×	107 0.2×	139 0.5×	53 0.2×	110	1.2k

Countries citing papers authored by Eduardo Tschen

Since Specialization

Citations

This map shows the geographic impact of Eduardo Tschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Tschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Tschen more than expected).

Fields of papers citing papers by Eduardo Tschen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Tschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Tschen. The network helps show where Eduardo Tschen may publish in the future.

Co-authorship network of co-authors of Eduardo Tschen

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Tschen. A scholar is included among the top collaborators of Eduardo Tschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Tschen. Eduardo Tschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eichenfield, Lawrence F., Robert S. Call, Douglass W. Forsha, et al.. (2017). Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. Journal of the American Academy of Dermatology. 77(4). 641–649.e5. 109 indexed citations

Zane, Lee T., Leon Kircik, Robert S. Call, et al.. (2016). Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study. Pediatric Dermatology. 33(4). 380–387. 61 indexed citations

Eichenfield, Lawrence F., Robert S. Call, Douglass W. Forsha, et al.. (2016). 280 Long-term safety of crisaborole topical ointment, 2%, in atopic dermatitis. Journal of Investigative Dermatology. 136(5). S49–S49. 1 indexed citations

Anderson, Lawrence L., George Schmieder, Wm. Philip Werschler, et al.. (2009). Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. Journal of the American Academy of Dermatology. 60(6). 934–943. 101 indexed citations

Tschen, Eduardo, et al.. (2006). Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. British Journal of Dermatology. 155(6). 1262–1269. 114 indexed citations

Torok, Helen, Terry M. Jones, Phoebe Rich, Stacy Smith, & Eduardo Tschen. (2005). Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.. PubMed. 75(1). 57–62. 61 indexed citations

Kempers, Steven, Mark Boguniewicz, Eric Carter, et al.. (2004). A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. Journal of the American Academy of Dermatology. 51(4). 515–525. 88 indexed citations

Olsen, Elise A., et al.. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 47(3). 377–385. 271 indexed citations

Wolf, John E., et al.. (2001). Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. International Journal of Dermatology. 40(11). 709–713. 161 indexed citations

10.

Lebwohl, Mark, C. Ralph Daniel, William D. James, et al.. (2001). Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis. International Journal of Dermatology. 40(5). 358–360. 22 indexed citations

11.

Tschen, Eduardo & A Bucko. (1998). Assessment of HPA-Axis Suppression with Fluticasone Cream 0.05% in Patients with Extensive Psoriasis or Eczema. Clinical Drug Investigation. 16(2). 111–116. 5 indexed citations

12.

Rich, Phoebe, Richard K. Scher, Debra Breneman, et al.. (1998). Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail. Journal of the American Academy of Dermatology. 38(6). S103–S109. 31 indexed citations

13.

Weinstein, Gerald D., Gerald G. Krueger, Nicholas J. Lowe, et al.. (1997). Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. Journal of the American Academy of Dermatology. 37(1). 85–92. 131 indexed citations

14.

Savin, Ronald, Paul R. Bergstresser, Henry E. Jones, et al.. (1994). Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: Results of placebo-controlled multicenter trials. Journal of the American Academy of Dermatology. 30(4). 663–667. 20 indexed citations

15.

Bergstresser, Paul R., Jon M. Hanifin, Jack L. Lesher, et al.. (1993). Topical terbinafine and clotrimazole in interdigital tinea pedis: A multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens. Journal of the American Academy of Dermatology. 28(4). 648–651. 53 indexed citations

16.

Berman, Brian, Charles N. Ellis, William D. James, et al.. (1992). Efficacy of a 1-week, twice-daily regimen of terbinafine 1 % cream in the treatment of interdigital tinea pedis. Journal of the American Academy of Dermatology. 26(6). 956–960. 55 indexed citations

17.

Macdonald, E. M., et al.. (1992). Comparison of skin changes induced on mice by either group A type 12 or group G streptococci. Experimental Dermatology. 1(5). 253–258. 1 indexed citations

18.

Olsen, Elise A., M. Lisa Abernethy, Carol L. Kulp‐Shorten, et al.. (1991). A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. Journal of the American Academy of Dermatology. 24(5). 738–743. 303 indexed citations

19.

Bekker, Linda‐Gail, et al.. (1988). Topical tioconazole in tinea pedis. Advances in Therapy. 5(6). 313–318. 5 indexed citations

20.

Tschen, Eduardo, et al.. (1986). Treatment of interdigital tinea pedis and tinea (pityriasis) versicolor with bifonazole 1% solution applied once daily. Advances in Therapy. 3(5). 250–256. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact